The first novel coronavirus case was reported on December 2019, in Wuhan, China (Xu et al., 2020), named by WHO as SARS-CoV2 and the causing disease as coronavirus disease 2019 (COVID2019). The genome sequence revealed that the virus is belongs to the beta-coronavirus group, sharing ancestry with bat coronavirus HKU9-1, similar to SARS-coronaviruses.1 The number of cases has increased within few weeks, and later spread beyond the China border.2 The epidemic of COVID-19 began in Africa later than other regions globally, perhaps, because of the limited international air traffic, rather than the climate conditions. In Africa, the first cases were reported in early March 2020 in Egypt, followed by Algeria, and Sudan.3 Sudan is located in the north-eastern Africa it occupies 1.882.000 million km square, making it third-largest country in Africa, and 16th in the world, with a population of over 40 million people.4 and Khartoum is the capital which is the main international air travel hub. Khartoum is considered the epi centre of majority of reported and imported COVID-19 cases. In this letter we describe the impact of COVID 19 in Sudan; highlighting the response towards COVID-19 pandemic and the challenges towards possible control and prevention the outbreak

Case-based surveillance measles data was defined according to World Health Organization (WHO) guidelines. A total of 511 measles cases were studied from 2011 to 2015 in Southern Darfur State, Sudan and 58.1% of cases were confirmed from Nyala city. About 43.4% of cases were males, 56.6% of cases were female, and 47.7% were children under five years old. Similarity, within February to June, the cases increased by 8.0% in children vaccinated through measles campaign, and 5.3% in children that used child vaccination card and 78.7% in unvaccinated one. The epidemiologically linked (EPI-Linked) measles cases declined from 2011 to 2015; consequently, Measles still remain to be a significant challenge in south Darfur state, Sudan.